Genotech Corporation (XKON:066830)
South Korea · Delayed Price · Currency is KRW 1,190.00
-6.00 (-0.50%)
At close: Aug 21, 2025, 3:30 PM KST
Genotech Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | 2006 - 2010 |
|---|---|---|---|---|---|---|
Period Ending | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | 2006 - 2010 |
Operating Revenue | 7,281 | 6,449 | 6,286 | 6,935 | 6,539 | Upgrade |
Other Revenue | -0 | - | - | 0 | 0 | Upgrade |
| 7,281 | 6,449 | 6,286 | 6,935 | 6,539 | Upgrade | |
Revenue Growth (YoY) | 12.91% | 2.59% | -9.36% | 6.05% | -5.51% | Upgrade |
Cost of Revenue | 6,319 | 5,205 | 5,881 | 4,855 | 4,416 | Upgrade |
Gross Profit | 962.09 | 1,243 | 405.12 | 2,080 | 2,123 | Upgrade |
Selling, General & Admin | 1,359 | 1,121 | 1,188 | 1,190 | 1,172 | Upgrade |
Research & Development | 396.43 | 65.36 | 243.46 | 232.18 | 179.02 | Upgrade |
Other Operating Expenses | 110.27 | 99.78 | 93.43 | 93.01 | 87.89 | Upgrade |
Operating Expenses | 1,974 | 1,240 | 1,575 | 1,526 | 1,460 | Upgrade |
Operating Income | -1,012 | 3.22 | -1,170 | 554.41 | 662.88 | Upgrade |
Interest Expense | -382.76 | -428.91 | -269.43 | -313.43 | -384.34 | Upgrade |
Interest & Investment Income | 7.48 | 7.95 | 10.17 | 25.08 | 6.01 | Upgrade |
Currency Exchange Gain (Loss) | 72.7 | 24.67 | 21.59 | 2.8 | - | Upgrade |
Other Non Operating Income (Expenses) | 12.19 | 1.88 | 11.75 | 7.09 | 179.88 | Upgrade |
EBT Excluding Unusual Items | -1,303 | -391.18 | -1,395 | 275.96 | 464.43 | Upgrade |
Asset Writedown | -18.63 | - | -830.8 | - | -65.2 | Upgrade |
Other Unusual Items | - | 14.4 | - | 131.33 | - | Upgrade |
Pretax Income | -1,321 | -376.78 | -2,226 | 407.28 | 399.23 | Upgrade |
Net Income | -1,321 | -376.78 | -2,226 | 407.28 | 399.23 | Upgrade |
Net Income to Common | -1,321 | -376.78 | -2,226 | 407.28 | 399.23 | Upgrade |
Net Income Growth | - | - | - | 2.02% | 41.32% | Upgrade |
Shares Outstanding (Basic) | 5 | 5 | 4 | 4 | 4 | Upgrade |
Shares Outstanding (Diluted) | 5 | 5 | 4 | 4 | 4 | Upgrade |
Shares Change (YoY) | 2.69% | 7.53% | -0.33% | -0.13% | 0.29% | Upgrade |
EPS (Basic) | -280.00 | -82.00 | -521.00 | 95.00 | 93.00 | Upgrade |
EPS (Diluted) | -280.00 | -82.00 | -521.00 | 95.00 | 93.00 | Upgrade |
EPS Growth | - | - | - | 2.15% | 40.91% | Upgrade |
Free Cash Flow | 125.36 | 883.68 | -1,026 | 609.39 | -34.6 | Upgrade |
Free Cash Flow Per Share | 26.57 | 192.32 | -240.21 | 142.14 | -8.06 | Upgrade |
Gross Margin | 13.21% | 19.28% | 6.44% | 30.00% | 32.47% | Upgrade |
Operating Margin | -13.90% | 0.05% | -18.61% | 7.99% | 10.14% | Upgrade |
Profit Margin | -18.14% | -5.84% | -35.42% | 5.87% | 6.11% | Upgrade |
Free Cash Flow Margin | 1.72% | 13.70% | -16.33% | 8.79% | -0.53% | Upgrade |
EBITDA | -347.19 | 1,151 | -336.89 | 1,854 | 2,181 | Upgrade |
EBITDA Margin | -4.77% | 17.84% | -5.36% | 26.73% | 33.35% | Upgrade |
D&A For EBITDA | 664.99 | 1,148 | 832.7 | 1,299 | 1,518 | Upgrade |
EBIT | -1,012 | 3.22 | -1,170 | 554.41 | 662.88 | Upgrade |
EBIT Margin | -13.90% | 0.05% | -18.61% | 7.99% | 10.14% | Upgrade |
Advertising Expenses | 12.5 | 11.2 | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.